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A
 
BSTRACT
 
Eosinophilic myocarditis is characterized by an acute
inflammatory infiltration of eosinophils in the myo-
cardium. Diagnosis is confirmed by a heart muscle
biopsy. Immunopathological studies suggest that
several toxic proteins, such as eosinophilic cationic
protein (ECP) derived from the degranulation of
eosinophils, may play an important role in the patho-
genesis of this cardiac disorder. Serum levels of ECP,
which are related to the inflammatory activity of the
disease are used to monitor and determine the effects
of treatment in adult patients. Herein, we present the
case of a 12-year-old, previously healthy, junior high
school girl with eosinophilic myocarditis. The diagnosis
was confirmed by a myocardial biopsy and the patient
was treated successfully with prednisolone. On admis-
sion, her peripheral blood eosinophil count (3342 /
 
µ
 
L)
and serum ECP level (124 
 
µ
 
g/L) were extremely high,
but both decreased significantly during corticosteroid
therapy. In the present case, corticosteroid treatment
was successful and early diagnosis by endomyocardial
biopsy is recommended. Furthermore, serum ECP is
useful to monitor the efficacy of treatment in pediatric
patients.
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I
 
NTRODUCTION
 
Eosinophilia is often associated with heart disease, but
the mechanisms of sustained overproduction of eosino-
phils and endomyocardial damage remains unknown.
Although the heart is mainly damaged in patients with
hypereosinophilic syndrome,
 
1,2
 
 the mechanism respon-
sible for myocardial damage remains unknown. Eosino-
phil cationic protein (ECP) or major basic protein (MBP)
from activated eosinophils have been reported to stimu-
late the release of histamine and tryptase, which cause
heart damage.
 
3
 
Eosinophilic myocardial disease is a single entity that
includes eosinophilic myocarditis, Löffler’s endomyo-
carditis and endomyocardial fibrosis. Many chronic types
of eosinophilic myocarditis have been reported and most
occur as a complication of systemic disease with extra-
cardiac involvement, such as hypereosinophilic syn-
drome,
 
4
 
 eosinophilic leukemia, polyarteritis nodosa and
bronchial asthma. Moreover, it is generally accepted that
there are usually some causes for eosinophilia, including
parasitic infection, allergic disease, lymphoma, carci-
noma and drug-induced allergy, with myocarditis being
just a symptom.
Herein, we report a pediatric case of acute eosino-
philic myocarditis without notable extracardiac involve-
ment, which was diagnosed by endomyocardial biopsy.
The patient was treated successfully with prednisolone
and the serum level of ECP was found to serve as a useful
marker of disease activity.
 
C
 
LINICAL
 
 
 
SUMMARY
 
A 12-year-old girl, previously in good health, developed
a fever of 37.5
 
°
 
C, coughing and mild dyspnea on
16 May 2000. She was treated with norfloxacin and
loxoprofen sodium under the diagnosis of upper respira-
tory tract infection. Three days later, her symptoms had
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improved so she went to school. At school, she suffered
convulsions, fainted and was admitted to a near-by
hospital on 19 May 2000. A chest radiograph revealed
cardiomegaly and echocardiographic findings indicated
left ventricular dysfunction and pericardial effusion.
Therefore, the patient was transferred to our hospital on
the same day. She had a history of atopic dermatitis and
her mother has allergic rhinitis. There was no history of
traveling outside of Japan.
On admission, the patient had cyanosis and her con-
sciousness was clear. Her body temperature was 37.9
 
°
 
C,
pulse 120 beats/min, blood pressure 90/40 mmHg and
respiratory rate 50 /min. A Levine 1/6 pansystolic murmur
was ausculated at the left sternal border. No crackles
were found in any lung field. The liver was not enlarged,
but the patient’s face and legs were mildly edematous.
The results of laboratory tests were as follows: white
blood cell count 10 040 /
 
µ
 
L with 34% eosinophils, total
protein 6.2 g/dL (normal 6.9–8.3), albumin 3.5 g/dL
(normal 4.3–5.4), creatine kinase 287 IU/L (normal
39–163), creatine kinase muscle brain (CKMB) 17 IU/L
(normal 5–15), aspartate aminotransferase 27 IU/L
(normal 14–32), alanine aminotransferase 22 IU/L
(normal 9–25), lactate dehydrogenase 267 IU/L (normal
116–199), blood urea nitrogen 18 mg/dL (normal
8–20) and creatinine 0.55 mg/dL (normal 0.48–0.82).
C-Reactive protein was 0.7 mg/dL and the erythrocyte
sedimentation rate was 14 mm/h. Antinuclear antibody
was negative and C3, C4 and CH50 were 34, 26 mg/dL
and 43.6 U/mL, respectively. The serum IgG, IgA, IgM
and IgE levels were 1080, 177 and 252 mg/dL and
307 IU/mL, respectively. Fibrinogen degradation product-E
was 234 ng/mL (normal < 60). Soluble interleukin (IL)-2
receptor was 1620 U/mL (normal 220–530), 2–5 oligo-
adenylic acid synthetase (2–5 AS) was 116 pmol/dL
(normal <100) and 
 
β
 
2
 
-microglobulin was 1.78 mg/L
(normal 0.85–1.71). Serological tests for antibodies
against viruses including Coxsakie B(1–6) were negative.
Bone marrow examination revealed a normocellular
marrow with an increase of immature eosinophils
(16.2%). Stool examinations for ova and parasites were
negative.
The patient’s chest radiograph showed cardiomegaly
(cardiothoracic ratio (CTR): 64%) and pulmonary con-
gestion (Fig. 1a). Her electrocardiogram presented low
voltage and showed right axis deviation. M-Mode
echocardiography revealed a posterior pericardial effu-
sion of 14 mm (Fig. 1b). The left ventricular posterior wall
was 10 mm thick and fractional shortening (FS) was 17%.
There was moderate mitral and tricuspid regurgitation.
There was no abnormality on head computed tomog-
raphy and electroencephalography. The patient’s symp-
toms and left ventricular dysfunction improved after
starting treatment with dopamine, dobutamine and furo-
semide (Fig. 2). However, the improvement of cardio-
megaly and cardiac dysfunction was not satisfactory.
Furthermore, the eosinophil count increased to 4295 /
 
µ
 
L
(37%) and ECP increased to 124 
 
µ
 
g/L. Therefore, a right
ventricular endomyocardial biopsy was performed on
25 May 2000. The biopsy revealed large numbers of
eosinophils located predominantly in the interstitium
(Fig. 3). Moreover, there was mild to moderate necrosis
of the myocardium. There was no evidence of vasculitis,
myocardial fibrosis or granulomas. A diagnosis of acute
necrotizing eosinophilic myocarditis was made. Then, the
patient was started on oral prednisolone (50 mg/day),
which resulted in a decrease in the eosinophil count and
ECP to levels within the normal range (Fig. 2). The
patient’s cardiac function improved significantly 10 days
after admission; posterior pericardial effusion decreased
to 0–4 mm, the left ventricular posterior wall thickness
decreased to 8 mm and FS increased to 38%. The patient
was discharged on 17 June 2000 with an eosinophil
count of 0% and ECP level of 7 
 
µ
 
g/L. The prednisolone
was gradually tapered down until it was withdrawn by the
end of July 2000. Since then, the patient has been doing
well without any cardiac events. Electrocardiographic
and echocardiographic findings have remained normal
during the more than 2 year follow up.
 
D
 
ISCUSSION
 
Recently, several cases of eosinophilic myocarditis,
including an infant case,
 
5
 
 have been reported;
 
6,7
 
however, the pathophysiology of the disease remains
unknown. Recent studies regarding the development of
eosinophilia have shown that the abnormal proliferation
of eosinophils is due to an expanded population of
CD4
 
–
 
CD8
 
–
 
 T cells, which produce cytokines with anti-
apoptotic properties for eosinophils,
 
8
 
 due to the over-
production of IL-5 by monoclonal expansion of
CD3
 
–
 
CD4
 
+
 
 Th2-like lymphocytes in patients with eosi-
nophilic myocarditis
 
9
 
 and due to the lower susceptibility
to apoptosis of Th2 cells in these patients.
 
10
 
The diagnostic criteria for hypereosinophilic syndrome
(HES) have been proposed by Chusid 
 
et al
 
.
 
11
 
 as follows:
(i) persistent eosinophilia of more than 1500 /
 
µ
 
L for
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6 months or longer, or death associated with the signs
and symptoms of hypereosinophilic disease; (ii) no evi-
dence of known causes of eosinophilia; and (iii) pre-
sumptive signs and symptoms of organ involvement.
We diagnosed our patient as having HES associated
with myocarditis based on her clinical data, laboratory
tests and the histological study of a biopsy specimen.
Despite our extensive studies, the cause of our patient’s
eosinophilia was not elucidated. Eosinophilia was detected
in association with the common cold and the heart was
the only organ involved. The duration of eosinophilia did
not fulfilll the criteria proposed by Chusid et al.11 in our
patient because of the prompt administration of steroid
therapy.
Three histological stages of eosinophilic endomyo-
cardial disease have been reported.1 The first is an acute
necrotizing phase, the second is a thrombotic phase and
the third is endomyocardial fibrosis. The second and third
phases are considered to correspond to Löffler’s endo-
myocarditis and restrictive myocarditis, respectively.12,13
Furthermore, the fulminant type of eosinophilic myo-
carditis is referred to as acute necrotizing myocarditis.12,13
Fig. 1 Chest radiographs and
echocardiograms of the patient.
(a) Chest radiograph on admis-
sion (left) and 1 week after
admission (right). The cardio-
megaly (cardiothoracic ratio
(CTR) 64%) and pulmonary con-
gestion observed on admission
(left) improved after initial therapy
(right). (b) Echocardiogram on
admission (left) and 1 week after
admission (right). The left ven-
tricular wall was swollen and
moderate pericardial effusion
was observed on admission.
These also improved after the
therapy. LVPWTd, left ventricular
posterior wall thickness diastole;
FS, fractional shortening.
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In our patient, the histological findings corresponded with
the acute necrotizing phase.
Drug-induced hypersensitivity myocarditis has also been
classified as hypereosinophilic myocardial disease.
 
14–16
 
Many drugs, such as methyldopa, sulfonamides, penicil-
lin and cephalosporins, have been described as causa-
tive agents of the disease. Our patient was administered
antibiotics and a non-steroidal anti-inflammatory drug;
 
Fig. 2
 
Clinical course and laboratory data of the patient. Despite the improvement in cardiac function, the eosinophil count
(maximum 4295 /
 
µ
 
L; 36%) and eosinophil cationic protein (ECP) level (124 
 
µ
 
g/L) continued to increase. These parameters
improved markedly after corticosteroid therapy. CTR, cardiothoracic ratio; FS, fractional shortening.
 
Fig. 3
 
Histopathological examination of a myocardium specimen obtained by endomyocardial biopsy. The histological section of
the patient’s myocardium shows diffuse interstitial infiltration of eosinophils and mild myocardial necrosis. (Hematoxylin and eosin;
original magnification 
 
×
 
100 (left); 
 
×
 
400 (right).)
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however, her illness did not meet the features of drug-
induced hypersensitivity myocarditis. That is, neither
vasculitis nor vascular involvement was seen. In addition,
we were able to exclude the possibility of Churg–Strauss
syndrome because of a lack of granulomas in the biopsy
speciment, the absence of vasculitis and the absence of
antineutrophil cytoplasmic antibody.
The presence of an elevated number of eosinophils in
the patient’s peripheral blood and myocardium and the
increased levels of serum ECP suggested that these cells
may play a direct part in causing cardiac dysfunction.
Moreover, it has been shown that proteins derived from
eosinophils, including ECP and MBP, would play signifi-
cant roles in damaging the myocardium in eosinophilic
myocarditis.
 
3,17
 
 The stimulating factor that attracts
eosinophils into the myocardium is obscure. Even mild
viral infections trigger eosinophilic activation when there
is an allergic disease. In our patient, there was a preced-
ing infection that may have triggered the disease.
Recently, two patients with eosinophilic myocarditis but
without peripheral hypereosinophilia have been reported.
 
18
 
Therefore, the absence of hypereosinophilia does not
exclude the presence of eosinophilic organ infiltration.
Furthermore, an endomyocardial biopsy may be the only
diagnostic procedure in patients with unexplained heart
failure.
The clinical symptoms of acute myocarditis are usually
minor and non-specific, such as fever and palpitation.
Therefore, echocardiography and electrocardiography
should be seriously considered for children with eosino-
philia. In addition, the serum level of ECP has been
reported to be a reliable indicator for diagnosis and in
determining treatment parameters for eosinophilic myo-
carditis in adults.
 
19,20
 
 Treatment of the disease should be
focused on the normalization of the eosinophil count,
which is accomplished primarily by the use of cortico-
steroids, on therapy for the associated heart failure and
on prophylactic anticoagulation. Steroids, anticoagulants,
antiplatelet drugs, hydroxyurea and azathioprine have
been advocated in the treatment of acute necrotizing
eosinophilic myocardial disease. In addition, high-dose
methylprednisolone has been reported to be useful in
patients affected by the disease.
 
21
 
 Our patient was
treated with prednisolone, which proved beneficial.
Finally, eosinophilic myocarditis is usually idiopathic
and it can cause sudden death in healthy young chil-
dren.
 
22
 
 Therefore, physicians should be aware of this
disease and the administration of steroids at an early
stage is desired. Further studies are necessary to establish
the most ideal treatment and diagnostic markers of the
disease.
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